StatPearls Question of the Week – #7

So far in the early clinical trials, chimeric antigen receptor-engineered T cells (CAR-T cells) have targeted which receptor in the treatment of acute lymphoblastic leukemia?

A. CD5

B. CD19

C. CD45

D. CD99

Click for the answer and teaching points.